IBN has collaborated with many multinational companies to develop solutions for real-world problems.


IBN has successfully licensed over 130 patents and patent applications, and established 12 spin-off companies.

Astral Nanotec

Astral Peptide

GreenT Biomed

SG Molecular Diagnostics

Wet Alert

SG Microlab Devices

Technology Portfolio

IBN has a portfolio of over 660 active patents and patent applications on its inventions, which have attracted significant market interest.


Synthetic Biosystems

Biodevices and Diagnostics

Green Chemistry and Energy